INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 143 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 2.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $224,000 | +5.7% | 13,234 | -16.3% | 0.00% | -50.0% |
| Q3 2014 | $212,000 | -84.5% | 15,819 | -85.3% | 0.00% | -66.7% |
| Q2 2014 | $1,372,000 | +10.2% | 107,776 | +3.0% | 0.01% | -25.0% |
| Q1 2014 | $1,245,000 | +89.8% | 104,654 | +120.3% | 0.01% | +100.0% |
| Q4 2013 | $656,000 | -41.4% | 47,500 | -26.0% | 0.00% | -42.9% |
| Q3 2013 | $1,119,000 | -14.6% | 64,203 | -20.6% | 0.01% | -12.5% |
| Q2 2013 | $1,310,000 | – | 80,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,100,000 | $14,762,000 | 6.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,882,805 | $52,107,000 | 1.90% |
| Cheyne Capital Management (UK) LLP | 326,821 | $4,388,000 | 1.56% |
| BB BIOTECH AG | 2,320,737 | $31,144,000 | 1.27% |
| Broadfin Capital, LLC | 854,384 | $11,466,000 | 1.20% |
| HealthCor Management, L.P. | 1,162,200 | $15,597,000 | 0.80% |
| Orbimed Advisors | 4,736,900 | $63,569,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 148,000 | $1,986,000 | 0.58% |
| SOUND ENERGY PARTNERS, INC. | 51,000 | $684,000 | 0.53% |
| Rock Springs Capital Management LP | 210,000 | $2,818,000 | 0.44% |